ATE301714T1 - Insulinartigen wachstumsfaktor bindendes protein -3 variante - Google Patents

Insulinartigen wachstumsfaktor bindendes protein -3 variante

Info

Publication number
ATE301714T1
ATE301714T1 AT99926092T AT99926092T ATE301714T1 AT E301714 T1 ATE301714 T1 AT E301714T1 AT 99926092 T AT99926092 T AT 99926092T AT 99926092 T AT99926092 T AT 99926092T AT E301714 T1 ATE301714 T1 AT E301714T1
Authority
AT
Austria
Prior art keywords
igfbp
variant
disclosed
growth factor
insulin
Prior art date
Application number
AT99926092T
Other languages
English (en)
Inventor
Desmond Mascarenhas
Stephen Danko
David Passmore
Original Assignee
Celtrix Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celtrix Pharma filed Critical Celtrix Pharma
Application granted granted Critical
Publication of ATE301714T1 publication Critical patent/ATE301714T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4743—Insulin-like growth factor binding protein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT99926092T 1998-06-01 1999-05-28 Insulinartigen wachstumsfaktor bindendes protein -3 variante ATE301714T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8755998P 1998-06-01 1998-06-01
US09/322,484 US6417330B1 (en) 1998-06-01 1999-05-27 Insulin-like growth factor binding protein variants
PCT/US1999/012087 WO1999063086A2 (en) 1998-06-01 1999-05-28 Insulin-like growth factor binding protein-3 variants

Publications (1)

Publication Number Publication Date
ATE301714T1 true ATE301714T1 (de) 2005-08-15

Family

ID=26777116

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99926092T ATE301714T1 (de) 1998-06-01 1999-05-28 Insulinartigen wachstumsfaktor bindendes protein -3 variante

Country Status (9)

Country Link
US (2) US6417330B1 (de)
EP (1) EP1082427B1 (de)
CN (1) CN1311819A (de)
AT (1) ATE301714T1 (de)
AU (1) AU761630B2 (de)
CA (1) CA2336295A1 (de)
DE (1) DE69926627T2 (de)
ES (1) ES2246088T3 (de)
WO (1) WO1999063086A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7109030B2 (en) * 2000-03-31 2006-09-19 Nuvelo, Inc. Methods of therapy and diagnosis using insulin-like growth factor binding protein-like polypeptides and polynucleotides
EP1455807A2 (de) 2000-09-19 2004-09-15 Bioexpertise, Llc Verfahren für die verwendung von igf-bindunsprotein zur selektiven sensibilisierung von zielzellen in vivo
US20050033035A1 (en) * 2001-06-07 2005-02-10 Hans-Georg Beisel Mutants of igf binding proteins and methods of production of antagonists thereof
US20050244422A1 (en) * 2004-04-16 2005-11-03 Desmond Mascarenhas Methods for delivering MBD peptide-linked agent into cells under conditions of cellular stress
US6914049B2 (en) 2001-09-18 2005-07-05 Bioexpertise, Llc IGF-binding protein-derived peptide or small molecule
EP1435986B1 (de) * 2001-09-18 2008-01-02 Bioexpertise, Llc Von igf-bindungsprotein stammendes peptid
US6887851B2 (en) * 2001-09-18 2005-05-03 Bioexpertise, Llc IGF-binding protein-derived peptide
US20050148509A1 (en) * 2003-07-09 2005-07-07 The University Of Iowa Research Foundation Binding proteins as chemotherapy
AR046071A1 (es) * 2003-07-10 2005-11-23 Hoffmann La Roche Anticuerpos contra el receptor i del factor de crecimiento de tipo insulinico y los usos de los mismos
AU2004278311A1 (en) * 2003-10-03 2005-04-14 Genentech, Inc. IGF binding proteins
CA2899824A1 (en) * 2004-12-24 2006-06-29 Insmed, Inc. Purified rhigf-i/rhigfbp-3 complexes and their method of manufacture
CN101495141B (zh) * 2005-12-13 2015-10-07 阿斯利康(瑞典)有限公司 胰岛素样生长因子特异性结合蛋白及其用途
PL1979001T3 (pl) * 2005-12-13 2012-09-28 Medimmune Ltd Białka wiążące specyficzne dla insulinopodobnych czynników wzrostu i ich zastosowania
US20120189641A1 (en) 2009-02-25 2012-07-26 OSI Pharmaceuticals, LLC Combination anti-cancer therapy
JP6190275B2 (ja) 2011-02-24 2017-08-30 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル Ｉｇｆｂｐ−３誘導体およびその使用
WO2013152252A1 (en) 2012-04-06 2013-10-10 OSI Pharmaceuticals, LLC Combination anti-cancer therapy
TWI723247B (zh) 2017-02-06 2021-04-01 中央研究院 重組蛋白及其用途

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4512922A (en) 1982-12-22 1985-04-23 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4511502A (en) 1982-12-22 1985-04-16 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4511503A (en) 1982-12-22 1985-04-16 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US5200509A (en) 1987-04-06 1993-04-06 Celtrix Pharmaceuticals, Inc. Human somatomedin carrier protein subunits and process for producing them; recombinant DNA molecules, hosts, processes and human somatomedin carrier protein-like polypeptides
US5258287A (en) * 1988-03-22 1993-11-02 Genentech, Inc. DNA encoding and methods of production of insulin-like growth factor binding protein BP53
US5187151A (en) 1991-02-12 1993-02-16 Genentech, Inc. Use of binding protein with igf-i as an anabolic growth promoting agent
US5288931A (en) 1991-12-06 1994-02-22 Genentech, Inc. Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation
US5407913A (en) 1992-12-03 1995-04-18 Celtrix Pharmaceuticals, Inc. Method and composition for systemic treatment of tissue injury
US5643867A (en) 1992-08-26 1997-07-01 Celtrix Pharmaceuticals, Inc. Method for treating catabolic conditions
US5459051A (en) 1993-03-26 1995-10-17 Celtrix Pharmaceuticals, Inc. Methods and vectors for over-expression of ubiquitin fusion proteins in host cells
US5563046A (en) 1993-08-02 1996-10-08 Celtrix Pharmaceuticals, Inc. Fusion polypeptides and proteins
ATE190499T1 (de) 1993-08-03 2000-04-15 Celtrix Pharma Methode zur behandlung von reproduktionserkrankungen
US5663304A (en) 1993-08-20 1997-09-02 Genentech, Inc. Refolding of misfolded insulin-like growth factor-I
ATE226958T1 (de) 1993-09-20 2002-11-15 Celtrix Pharma Behandlung von hematologischen störungen mit einem igf-1/igfbp-3 komplex
AU693489B2 (en) 1993-11-15 1998-07-02 Celtrix Pharmaceuticals, Inc. Method of treating neurological disorders
AU690941B2 (en) 1993-11-15 1998-05-07 Celtrix Pharmaceuticals, Inc. Method of treating renal disease by administering IGF-I and IGFBP-3
SE9303784D0 (sv) 1993-11-16 1993-11-16 Kabi Pharmacia Ab Igf
US5861273A (en) 1993-12-21 1999-01-19 Celtrix Phamraceuticals, Inc. Chromosomal expression of heterologous genes in bacterial cells
WO1996002565A1 (en) 1994-07-20 1996-02-01 Celtrix Pharmaceuticals, Inc. Igf/igfbp complex for promoting bone formation and for regulating bone remodeling
US5789547A (en) 1995-06-07 1998-08-04 Celtrix Pharmaceuticals, Inc. Method of producing insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-3 (IGFBP-3) with correct folding and disulfide bonding

Also Published As

Publication number Publication date
EP1082427B1 (de) 2005-08-10
DE69926627D1 (de) 2005-09-15
DE69926627T2 (de) 2006-05-24
AU4225299A (en) 1999-12-20
WO1999063086B1 (en) 2000-04-20
CA2336295A1 (en) 1999-12-09
AU761630B2 (en) 2003-06-05
ES2246088T3 (es) 2006-02-01
CN1311819A (zh) 2001-09-05
EP1082427A2 (de) 2001-03-14
US6417330B1 (en) 2002-07-09
WO1999063086A8 (en) 2000-08-10
WO1999063086A2 (en) 1999-12-09
WO1999063086A3 (en) 2000-01-27
US20020072589A1 (en) 2002-06-13

Similar Documents

Publication Publication Date Title
DE69926627D1 (de) Insulinartigen wachstumsfaktor bindendes protein -3 variante
ATE352617T1 (de) Lösliche polypeptidfraktionen des lag-3-proteins; verfahren zur herstellung; therapeutische zusamensetzung; antiidiotypischer antikörper
ATE368053T1 (de) Antimikrobielle peptide
BG102983A (en) Extramembrane protein 106 polypeptide of moraxella catarrhalis, its gene sequence and application
GB9108652D0 (en) Immunoreactive compounds
WO1998055508A3 (en) HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS
ATE135371T1 (de) Mit akuter pankreatitis assoziiertes protein, mittel zur diagnose von akuter pankreatitis
CA2249180A1 (en) Methods for recombinant microbial production of bpi-fusion proteins and bpi-derived peptides
PT731811E (pt) Chaperonina 10
WO2002008426A3 (en) Fh-binding protein of streptococcus pneumoniae
EP0082568A3 (en) Retro-inverso analogues of c-terminal penta and hexapeptides of substance p.
EP1006126A3 (de) Peptide mit osteogener Aktivität
EP0161007A3 (de) Retro-inverso C-Terminal-Hexapeptid-Analoga von der Verbindung P
AU5508396A (en) Pcna binding substance
ATE356831T1 (de) Neuer galaninrezeptor
DE69734596D1 (de) "smoothened" proteine aus wirbeltieren
ATE294816T1 (de) Neue, physiologisch aktive peptide und ihre verwendung.
WO2000000506A3 (en) Human proteins having hydrophobic domains and dnas encoding these proteins
AU1993201A (en) Nucleic acid sequences of hyperplasia and tumours of the thyroid
EP1040351A4 (de) C-terminale region des "agouti-related-transcript"-proteins (art)
WO2003044159A9 (en) Zinc finger proteins, polynucleotides encoding same and antibodies thereto
DE60021707D1 (de) Beta-primeverosidase gen
NZ606260A (en) Novel polypeptides involved in immune response

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1082427

Country of ref document: EP

REN Ceased due to non-payment of the annual fee